An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum -Infected Red Cells Binds to Chondroitin Sulfate A

Archive ouverte

Keitany, Gladys | Jenkins, Bethany | Obiakor, Harold | Daniel, Shaji | Muehlenbachs, Atis | Semblat, Jean-Philippe | Gamain, Benoît | Doritchamou, Justin | Desai, Sanjay | Macdonald, Nicholas | Narum, David | Morrison, Robert | Saveria, Tracy | Vignali, Marissa | Oleinikov, Andrew | Fried, Michal | Duffy, Patrick

Edité par CCSD ; Oxford University Press -

International audience. Abstract Background Plasmodium falciparum-infected red blood cells (iRBCs) bind and sequester in deep vascular beds, causing malaria-related disease and death. In pregnant women, VAR2CSA binds to chondroitin sulfate A (CSA) and mediates placental sequestration, making it the major placental malaria (PM) vaccine target. Methods In this study, we characterize an invariant protein associated with PM called P falciparum chondroitin sulfate A ligand (PfCSA-L). Results Recombinant PfCSA-L binds both placental CSA and VAR2CSA with nanomolar affinity, and it is coexpressed on the iRBC surface with VAR2CSA. Unlike VAR2CSA, which is anchored by a transmembrane domain, PfCSA-L is peripherally associated with the outer surface of knobs through high-affinity protein-protein interactions with VAR2CSA. This suggests that iRBC sequestration involves complexes of invariant and variant surface proteins, allowing parasites to maintain both diversity and function at the iRBC surface. Conclusions The PfCSA-L is a promising target for intervention because it is well conserved, exposed on infected cells, and expressed and localized with VAR2CSA.

Consulter en ligne

Suggestions

Du même auteur

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

Archive ouverte | Doritchamou, Justin | CCSD

International audience. Abstract Placental malaria vaccines (PMVs) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading candidate vaccine antige...

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults

Archive ouverte | Sagara, Issaka | CCSD

International audience. BACKGROUND:Pfs25H-EPA is a protein-protein conjugate transmission-blocking vaccine against Plasmodium falciparum that is safe and induces functional antibodies in malaria-naive individuals. I...

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial

Archive ouverte | Barry, Amadou | CCSD

International audience. BACKGROUND:Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is ...

Chargement des enrichissements...